STVN
Next earnings: Aug 4, 2026 · Before open
ANALYST COVERAGE8 analysts
BUY
+33.4%upside to target
L $17.50
Med $24.00consensus
H $32.00
Buy
563%
Hold
338%
5 Buy (63%)3 Hold (38%)0 Sell (-1%)
Full report →
Signal
Leaning Bullish1
Price
1
Move+0.00%Quiet session
Volume
1
Volume0.7× avgNormal activity
Technical
1
RSIRSI 50Momentum positive
PRICE
Prev Close
17.99
Open
17.67
Day Range17.38 – 18.00
17.38
18.00
52W Range12.89 – 28.00
12.89
28.00
34% of range
VOLUME & SIZE
Avg Volume
593.8K
FUNDAMENTALS
P/E Ratio
30.0x
EPS (TTM)
Div Yield
0.00%
Beta
1.00
Market-like
Key MetricsTTM
Market Cap$4.23B
Revenue TTM$1.20B
Net Income TTM$140.95M
Free Cash Flow-$7.11M
Gross Margin29.0%
Net Margin11.7%
Operating Margin16.6%
Return on Equity9.6%
Return on Assets5.5%
Debt / Equity0.29
Current Ratio1.63
EPS TTM$0.52
Upcoming Events
EEarnings Report
Tomorrow
May 18
DEx-Dividend
In 89 days
Aug 14
PDividend Pay
In 106 days
Aug 31

STVN News

About

founded in 1949, stevanato group is committed to create systems, processes and services that guarantee the integrity of parenteral medicines. it is comprised of two operational divisions: - pharmaceutical systems (ompi and balda brands): specialized in ready-to-use glass containers and bulk primary packaging (syringes, cartridges, vials and ampoules); high quality and high precision plastic solutions for diagnostic, pharmaceutical and medical device applications. - engineering systems (spami, optrel, innoscan and svm brands): specialized in glass forming technology, inspection systems, assembly, packaging machines and serialization solutions for the pharmaceutical industry. these two divisions enjoy a close, synchronous relationship, featuring daily exchanges which ensure that stevanato group has complete control over the entire production process, from purchasing the finest raw materials to offering exceptional after-sales customer service. the group also benefits from the sglab activ

Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Franco Moro
Country
Italy
Franco StevanatoChief Executive Officer & Executive Chairman
Marco Dal LagoChief Financial Officer
Mauro StocchiChief Business Officer
Michele MonicoPresident of DDS & IVD Business Unit
Raffaele PacePresident of Engineering Business Unit
Carla CostaChief Human Resources Officer
Lisa MilesChief Communications & Investor Relations Officer